Ranolazine: a new antiarrhythmic agent for patient...[Nat Clin Pract Cardiovasc Med. 2008] - PubMed Result

SearchDatabase nameforSearch term

Advanced Search

Your browser version may not work well with NCBI's Web applications. More information here...

Display Show

All: 1

Review: 0

Click to change filter selection through MyNCBI.

1: Nat Clin Pract Cardiovasc Med. 2008 May;5(5):248-9. Epub 2008 Mar 11. Links

Ranolazine: a new antiarrhythmic agent for patients with non-ST-segment elevation acute coronary syndromes?

Antzelevitch C.

Masonic Medical Research Laboratory, 2150 Bleecker Street, Utica, NY 13501-1787, USA. ca@mmrl.edu

PMID: 18332892 [PubMed]

PMCID: PMC2548402

Related articles

Effect of ranolazine, an antianginal agent with novel electrophysiological properties, on the incidence of arrhythmias in patients with non ST-segment elevation acute coronary syndrome: results from the Metabolic Efficiency With Ranolazine for Less Ischemia in Non ST-Elevation Acute Coronary Syndrome Thrombolysis in Myocardial Infarction 36 (MERLIN-TIMI 36) randomized controlled trial.
Circulation. 2007 Oct 9; 116(15):1647-52. Epub 2007 Sep 5.

[Circulation. 2007]
Evaluation of a novel anti-ischemic agent in acute coronary syndromes: design and rationale for the Metabolic Efficiency with Ranolazine for Less Ischemia in Non-ST-elevation acute coronary syndromes (MERLIN)-TIMI 36 trial.
Am Heart J. 2006 Jun; 151(6):1186.e1-9.

[Am Heart J. 2006]
Chronic kidney disease in patients with non-ST-segment elevation acute coronary syndromes.
Am J Med. 2006 Mar; 119(3):248-54.

[Am J Med. 2006]
ReviewUse of coronary revascularization in patients with unstable and non-ST-segment elevation acute myocardial infarction.
Am J Cardiol. 2001 Oct 18; 88(8A):25K-29K.

[Am J Cardiol. 2001]
ReviewRecent antiplatelet drug trials in the acute coronary syndromes. Clinical interpretation of PRISM, PRISM-PLUS, PARAGON A and PURSUIT.
Drugs. 1998 Dec; 56(6):965-76.

[Drugs. 1998]
» See reviews... | » See all...

Patient Drug Information

Ranolazine (Ranexa® )
Ranolazine is used alone or with other medications to treat ongoing angina (chest pain or pressure that is felt when the heart does not get enough oxygen). Ranolazine is in a class of medications called anti-anginals. Th...
Source: AHFS Consumer Medication Information

Recent Activity

Clear Turn Off Turn On

Ranolazine: a new antiarrhythmic agent for patients with non-ST-segment elevation acute co...Ranolazine: a new antiarrhythmic agent for patients with non-ST-segment elevation acute coronary syndromes?

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Display Show